価格表
在庫・価格 : 2025年10月08日 09時05分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-Human CXCL1/GRO alpha MAb (Clone 20326) データシート※最新のデータシートでない場合があります |
MAB275-100 |
RSDアールアンドディー システムズ R&D Systems, Inc. |
100 μg | ¥84,000 | 1個 | 追加 |
在庫・価格 : 2025年10月08日 09時05分 現在
Anti-Human CXCL1/GRO alpha MAb (Clone 20326)
- 商品コード:MAB275-100
- メーカー:RSD
- 包装:100μg
- 価格: ¥84,000
- 在庫:1個
使用文献
- No.: 1
-
文献情報:
Fong L et al. Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. Cancer Discov 2020 01;10(1):40-53
Fong L et al
2020/01/01
-
備考:
Species: Human, Applications: Flow Cytometry -
参照:
- No.: 2
-
文献情報:
Flaherty E et al. Neuronal impact of patient-specific aberrant NRXN1α splicing. Nat Genet 2019 12;51(12):1679-1690
Flaherty E et al
2019/01/01
-
備考:
Species: Human, Applications: Flow Cytometry -
参照:
- No.: 3
-
文献情報:
Kitawaki Y et al. Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma. Hum Pathol 2018 07;77:88-97
Kitawaki Y et al
2018/01/01
-
備考:
Species: Human, Applications: IHC-P -
参照:
- No.: 4
-
文献情報:
Ashander LM et al. Neutrophil Activities in Human Ocular Toxoplasmosis: An In Vitro Study With Human Cells. Invest Ophthalmol Vis Sci 2019 11;60(14):4652-4660
Ashander LM et al
2019/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 5
-
文献情報:
Gelderblom M et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012 Nov;120(18):3793-802
Gelderblom M et al
2012/01/01
-
備考:
Species: Human, Applications: IHC-P -
参照:
- No.: 6
-
文献情報:
Logue SE et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 2018 08;9(1):3267
Logue SE et al
2018/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 7
-
文献情報:
Numasaki M et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 2005 Nov;175(9):6177-89
Numasaki M et al
2005/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 8
-
文献情報:
Meen AJ et al. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J. Biol. Chem. 2011 Jan;286(4):2636-47
Meen AJ et al
2011/01/01
-
備考:
Species: Human, Applications: ICC -
参照:
- No.: 9
-
文献情報:
Moscova M et al. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines. Cancer Res. 2006 Feb;66(3):1376-83
Moscova M et al
2006/01/01
-
備考:
Species: Human, Applications: Immunodepletion -
参照:
- No.: 10
-
文献情報:
Oladipo O et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br. J. Cancer 2011 Feb;104(3):480-7
Oladipo O et al
2011/01/01
-
備考:
Species: Human, Applications: IHC-P -
参照:
- No.: 11
-
文献情報:
Kim EK et al. CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma. PLoS ONE 2018;13(1):e0188847
Kim EK et al
2018/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 12
-
文献情報:
Henry CM et al. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation. Mol. Cell 2017 Feb;65(4):715-729.e5
Henry CM et al
2017/01/01
-
備考:
Species: Human, Applications: ICC -
参照: